By Jonathan Stempel NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

CVS Health shares slipped after U.S. prosecutors accused the company of improper billing practices involving insulin pens ...

California lawmakers and Gov. Gavin Newsom have approved more than 900 new laws that will begin to take effect starting on ...

CVS will pay for dispensing and billing health care plans including Tricare for more insulin than was prescribed, according to a lawsuit settlement.

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become ...

Emerging research highlights vitamin D as a potential, overlooked factor in insulin resistance, a precursor to Type 2 ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

A compound that enables the delivery of insulin through the skin has been demonstrated in mice and minipigs. The findings, ...

CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.

Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.